Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 22, Issue 12

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 22, Issue 12 (2013)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 22, Issue 12 (2013)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Volume 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Metformin: an old drug with new potential

Joud Hajjar, Mouhammed Amir Habra & Aung Naing MD FACP

Pages: 1511-1517

Published online: 26 Aug 2013

AbstractforMetformin: an old drug with new potential | Full Text | References | PDF (359.3 KB)

3021 Views
23 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Omega-3 polyunsaturated fatty acids for major depressive disorder

Kuan-Pin Su, Sheng-Min Wang & Chi-Un Pae MD PhD

Pages: 1519-1534

Published online: 02 Oct 2013

AbstractforOmega-3 polyunsaturated fatty acids for major depressive disorder | Full Text | References | PDF (459 KB)

762 Views
39 CrossRef citations
0Altmetric

Review Article

New perspectives of valproic acid in clinical practice

Lenka Činčárová, Zbyněk Zdráhal & Jiří Fajkus

Pages: 1535-1547

Published online: 28 Oct 2013

AbstractforNew perspectives of valproic acid in clinical practice | Full Text | References | PDF (559 KB)

645 Views
49 CrossRef citations
0Altmetric

Review Article

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

Christopher D Verrico PhD, Colin N Haile MD PhD, Thomas F Newton MD, Thomas R Kosten MD & Richard De La Garza PhD

Pages: 1549-1568

Published online: 14 Sep 2013

AbstractforPharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications | Full Text | References | PDF (1.2 MB)

501 Views
28 CrossRef citations
0Altmetric

Review Article

New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β₂ agonists in combination or combined into a single molecule

Peter Norman MBA PhD

Pages: 1569-1580

Published online: 21 Aug 2013

AbstractforNew dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β₂ agonists in combination or combined into a single molecule | Full Text | References | PDF (610.6 KB)

521 Views
9 CrossRef citations
0Altmetric

Review Article

Changing trends in the treatment of dry-eye disease

Murat Dogru MD PhD, Masatsugu Nakamura PhD, Jun Shimazaki MD PhD & Kazuo Tsubota MD

Pages: 1581-1601

Published online: 03 Oct 2013

AbstractforChanging trends in the treatment of dry-eye disease | Full Text | References | PDF (1.1 MB)

1218 Views
41 CrossRef citations
0Altmetric

Review Article

Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis

Krisstina Gowin & Ruben Mesa

Pages: 1603-1611

Published online: 25 Sep 2013

AbstractforEmerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis | Full Text | References | PDF (314.7 KB)

463 Views
8 CrossRef citations
0Altmetric

Review Article

Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application

Zhijun Wang PhD, Jeffery Fan BS, Mandy Liu MS, Steven Yeung BS, Andy Chang BS, Moses SS Chow PharmD FCP FCCP, Doreen Pon PharmD BCOP BCPS & Ying Huang PhD

Pages: 1613-1626

Published online: 19 Sep 2013

AbstractforNutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application | Full Text | References | PDF (485.8 KB)

472 Views
23 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Article

Discontinued drugs in 2012: oncology drugs

Robert Williams PhD

Pages: 1627-1644

Published online: 08 Oct 2013

AbstractforDiscontinued drugs in 2012: oncology drugs | Full Text | References | PDF (320.3 KB)

707 Views
30 CrossRef citations
0Altmetric

Drug Evaluations

Capecitabine in the treatment of esophageal and gastric cancers

Elizabeta C Popa MD & Manish A Shah MD

Pages: 1645-1657

Published online: 04 Oct 2013

Abstractfor Capecitabine in the treatment of esophageal and gastric cancers | Full Text | References | PDF (491.5 KB)

340 Views
8 CrossRef citations
0Altmetric

The role of quizartinib in the treatment of acute myeloid leukemia

Fabiana Ostronoff & Elihu Estey

Pages: 1659-1669

Published online: 26 Sep 2013

AbstractforThe role of quizartinib in the treatment of acute myeloid leukemia | Full Text | References | PDF (397.9 KB)

843 Views
13 CrossRef citations
0Altmetric

The potential of sunitinib as a therapy in ovarian cancer

Umberto Leone Roberti Maggiore MD, Mario Valenzano Menada MD, Pier Luigi Venturini MD & Simone Ferrero MD PhD

Pages: 1671-1686

Published online: 26 Sep 2013

AbstractforThe potential of sunitinib as a therapy in ovarian cancer | Full Text | References | PDF (496.1 KB)

324 Views
16 CrossRef citations
0Altmetric

Lersivirine – a new drug for HIV infection therapy

Martin Platten MD & Gerd Fätkenheuer MD

Pages: 1687-1694

Published online: 16 Oct 2013

Abstractfor Lersivirine – a new drug for HIV infection therapy | Full Text | References | PDF (338 KB)

188 Views
8 CrossRef citations
0Altmetric

Appendix

Correction

Erratum

Page: 1695

Published online: 12 Nov 2013

CitationforErratum | Full Text | PDF (33.9 KB)

351 Views
0 CrossRef citations
0Altmetric

Free Access

Research Article

Article

Page: i

Published online: 12 Nov 2013

75 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

From bench to bedside - is there a role of IL-17 drugs in rheumatoid arthritis?

Swetha Byravan et al.

Review Article | Published online: 9 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.22, Iss.12, 2013)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?